Glaxo to end payments to prescribing doctors - WICU12 HD WSEE Erie, PA News, Sports, Weather, Events

Glaxo to end payments to prescribing doctors

Updated: Dec 17, 2013 02:52 PM
© iStockphoto.com / Claude Dagenais © iStockphoto.com / Claude Dagenais
  • Chris Lifestyle Category TESTMore>>

  • COPY-Chris Test 2

    Chris Test 2

    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>
  • Chris Test 1

    Chris Test 1

    Monday, February 6 2012 4:05 PM EST2012-02-06 21:05:06 GMT
    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>

By Margaret Steele
HealthDay Reporter

TUESDAY, Dec. 17, 2013 (HealthDay News) -- GlaxoSmithKline, the British pharmaceutical giant, says it will stop paying doctors to market its drugs at conferences and will no longer reward sales agents whose physician customers write the most prescriptions.

These practices are commonplace within the pharmaceutical industry, and critics have worried that they increase the likelihood that drug prescriptions will be written inappropriately.

Monday's announcement is apparently a first for a major drug company. But other companies may be considering similar moves, The New York Times reported.

One expert called the decision a small step in the right direction.

"It's a modest acknowledgment of the fact that learning from a doctor who is paid by a drug company to give a talk about its products isn't the best way for doctors to learn about those products," Dr. Jerry Avorn, a professor at Harvard Medical School who has studied the industry's marketing practices, told the Times.

However, Avorn pointed out that the company still planned to offer what Glaxo termed in a statement "unsolicited, independent educational grants" to inform doctors about its products. This practice in the past has raised questions about whether the grant recipients -- often for-profit companies -- provide independent information, Avorn said.

Under Glaxo's new plan, which will unfold worldwide by 2016, the company will stop paying doctors to attend medical conferences on its behalf. While this practice is frowned upon in the United States, it is commonplace in other countries, according to the news report.

In the United States, the new Affordable Care Act will require all payments by pharmaceutical companies to doctors be made public starting in 2014.

Glaxo said its decision was not linked to its current problems in China, where the company is accused of bribing doctors and public officials in an attempt to fuel sales. Chinese authorities claim that Glaxo financed doctors' trips to nonexistent conferences and talks.

Glaxo chief executive Andrew Witty told the Times that the change in business practices was in the works for years. It is an attempt "to try and make sure we stay in step with how the world is changing," he said. "We keep asking ourselves, are there different ways, more effective ways of operating than perhaps the ways we as an industry have been operating over the last 30, 40 years?"

Starting in 2015, Glaxo said, its worldwide sales staff will be paid for its service and expertise, not the number of Glaxo prescriptions that doctors write. The company stopped that practice in the United States in 2011, according to the Times.

Glaxo makes many well-known medications, including the antibiotic Augmentin; asthma medications Advair and Flovent; the epilepsy drug Lamictal; Lovaza for lowering cholesterol, and Avodart for prostate enlargement. It also makes Cervarix and Pediarix vaccines, over-the-counter products including Tums and toothpastes, and smoking-cessation products NicoDerm and Nicorette.

More information

The U.S. National Institutes of Health can help you choose the right doctor.

Copyright © 2013 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
3514 State St. Erie, PA 16508
Newsroom: (814)454-8812
Toll Free: 1(800)454-8812
Business offices: (814)454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
Mobile:
Mobile Site
Be sure to stay constantly updated with the power of WICU12 and WSEE at your fingertips
Free Android App
Free iPhone App
Free iPad App
Storm Tracker App
Droid
iPhone
iPad
All content © Copyright 2000 - 2014 WorldNow and WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com